Hanmi Pharmaceutical
008930.KS
S$39.04
Share price
-3.58%
Change (1 day)
20.26%
Change (1 year)
Categories
Earnings for Hanmi Pharmaceutical (008930.KS)
Earnings in 2025 (TTM): S$0.33 Billion
According to Hanmi Pharmaceutical 's latest financial reports the company's current earnings are S$0.92 Billion. In 2024 the company made an earning of S$71.22 Million a decrease over its 2023 earnings that were of S$0.13 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Hanmi Pharmaceutical from 2012 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | S$0.33 B | 376.42% |
| 2024 | S$71.22 M | -47.76% |
| 2023 | S$0.13 B | 79.52% |
| 2022 | S$75.95 M | 35.13% |
| 2021 | S$56.2 M | 59.02% |
| 2020 | S$35.34 M | -13.37% |
| 2019 | S$40.8 M | 75.79% |
| 2018 | S$23.21 M | -40.57% |
| 2017 | S$39.05 M | 59.34% |
| 2016 | S$24.51 M | -90.55% |
| 2015 | S$0.25 B | 891.26% |
| 2014 | S$26.17 M | 89.01% |
| 2013 | S$13.85 M | -18.07% |
| 2012 | S$16.9 M |